Imiquimod induced vitiligo:An HLA case investigated
Keywords:
imiquimod, HLA, VITILIGO, WARTSReferences
Wang Y, Li S, Li C. Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo. Clin Rev Allergy Immunol. 2021 Dec;61(3):299-323. DOI: 10.1007/s12016-021-08868-z. Epub 2021 Jul 20. Erratum in: Clin Rev Allergy Immunol. 2021 Dec;61(3):449. DOI: 10.1007/s12016-021-08884-z. PMID: 34283349.
Misri R, Khopkar U, Shankarkumar U, et al. Comparative case control study of clinical features and human leukocyte antigen susceptibility between familial and nonfamilial vitiligo. Indian J Dermatol Venereol Leprol. 2009 Nov-Dec;75(6):583-7. DOI: 10.4103/0378-6323.57719. PMID: 19915238
Yang S, Wang JY, Gao M, et al. Association of HLA-DQA1 and DQB1 genes with vitiligo in Chinese Hans. Int J Dermatol. 2005 Dec;44(12):1022-7. DOI: 10.1111/j.1365-4632.2004.02389.x. PMID: 16409268..
Kikili Cİ, Kivanç D, Ortaboz D, et al. Identification of HLA alleles involved in immune thrombotic thrombocytopenic purpura patients from Turkey. Blood Coagul Fibrinolysis. 2024 Sep 1;35(6):307-315. DOI: 10.1097/MBC.0000000000001318. Epub 2024 Jul 24. PMID: 39083057.
Wang HW, Miao F, Shi L et al. Imiquimod-induced localized vitiligo in wife and lichen planus in husband. Chin Med J (Engl). 2013 Jul;126(13):2593. PMID: 23823845.
Gandarillas S, Newland ES, Toppmeyer D, Stephenson R, Denzin L, Dasgeb B. HLA inherence as a potential parameter in checkpoint inhibitor-associated autoimmune adverse event assessment. Front Med (Lausanne). 2024;10:1288844. Published 2024 Jan 8. DOI:10.3389/fmed.2023.1288844. PMID: 38259857.
Published
Issue
Section
License
Copyright (c) 2025 Eleni Klimi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
